Urinary Tract Infection Treatment Market Research Report 2027

Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Penicillin and Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Nutritional Supplements), Indication (Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics, Retail Pharmacies and Drug Stores, Online Drug Stores), and Geography

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

[Research Report] The market is expected to reach US$ 11,614.32 million by 2027 from US$ 9,106.40 million in 2019; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027.

The growth of the market is attributed to the growing prevalence of urinary tract infections, aging population, and emerging computing technologies for urine diagnostics. However, the lack of product awareness in emerging countries and effects associated with medication obstruct the growth of the Urinary Tract Infection Treatment market to a certain extent.

Lucrative Regional Markets for Urinary Tract Infection Treatment



Lucrative Regional Markets for Urinary Tract Infection Treatment
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights


Growing Incidence of Urinary Tract Infections

Women are at a higher risk of developing urinary tract infections (UTIs) than men. UTIs, if go untreated, can lead to severe pain along with serious consequences to kidneys. UTIs show certain symptoms such as persistent urge to urinate, inflammation, change in appearance of urine, and nausea. The increasing prevalence of UTIs is one of the prominent factors driving the growth of the urinary tract infection treatment market. For instance, according to a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, UTIs accounts for ~6 million physicians visits each year in the US.

Certain risk factors such as sexual activity, poor hygiene, and aging may cause UTIs. Increasing incidence of these risk factors are also estimated to drive the urinary tract infection treatment market growth by 2027. According to a study published in the International Journal of Environmental Research and Public Health in 2019, patients with existing chronic conditions such as coronary artery disease (CAD), chronic kidney disease (CKD), and diabetes mellitus (DM) have high possibilities of acquiring UTIs. Therefore, the high epidemiology of UTI generates demand for its treatment products, eventually driving the market growth.

Drug Class-Based Insights

Based on drug class, the quinolones segment held the largest share of the market in 2019; however, the penicillin and combination segment is anticipated to register the highest CAGR of 4.5% in the market during the forecast period. The future growth of the market for quinolones is mainly ascribed to the fact that it is most commonly prescribed by physicians. Ciprofloxacin, levofloxacin, and enoxacin are among the most widely used drugs for treatment..

Urinary Tract Infection Treatment Market, by Drug Class – 2019 and 2027



Urinary Tract Infection Treatment Market, by Drug Class – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Indication-Based Insights

The urinary tract infection treatment market, by indication, is segmented into complicated urinary tract infections and uncomplicated urinary tract infections. The complicated urinary tract infections segment held a larger market share in 2019; also, the segment is anticipated to register a higher CAGR in the market during the forecast period.

Distribution Channel-Based Insights

The urinary tract infection treatment market, by distribution channel, is segmented into hospital pharmacies, gynecology and urology clinics, drug stores, retail pharmacies, and online drug stores. The hospital pharmacies distribution channel segment held the largest share of the market in 2019, whereas online drug stores segment is anticipated to register the highest CAGR in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Urinary Tract Infection Treatment Market: Strategic Insights

urinary-tract-infection-treatment-market
Market Size Value inUS$ 9,106.40 Million in 2019
Market Size Value byUS$ 11,614.32 Million by 2027
Growth rateCAGR of 3.2% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The urinary tract infection treatment market players—such as Shionogi & Co., Ltd.; Teva Pharmaceutical Industries Ltd;  Allergan; and Pfizer—have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in April 2019, Teva Pharmaceutical Industries Ltd announced the launch of a generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the US.

Urinary Tract Infection Treatment Market– by Drug Class

  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Aminoglycoside Antibiotics
  • Sulphonamides
  • Nutritional Supplements


Urinary Tract Infection Treatment Market– by Indication

  • Complicated Urinary Tract Infection
  • Uncomplicated Urinary Tract Infection


Urinary Tract Infection Treatment Market– by Distribution Channel

  • Hospital Pharmacies
  • Gynaecology and Urology Clinics
  • Retail Pharmacies and Drug Store
  • Online Drug Stores


Urinary Tract Infection Treatment Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East &Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V.
  • ALLERGAN
  • Pfizer Inc.
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Shionogi Inc.
  • Amway
  • DuPont Nutrition & Biosciences
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Drug Class , Indication , Distribution Channel , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

The List of Companies - Urinary Tract Infection Treatment Market

 

  1. Teva Pharmaceutical Industries Ltd
  2. Sun Pharmaceutical Industries Ltd
  3. Mylan N.V.
  4. ALLERGAN
  5. Pfizer Inc.
  6. Cipla Ltd
  7. F. Hoffmann-La Roche Ltd
  8. Shionogi Inc.
  9. Amway
  10. DuPont Nutrition & Biosciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Urinary Tract Infection Treatment Market